Location: Home
  • search
  • go
  • Relate News
  • 8/28/2017Chinese Patients Head to India for Latest Medicines after Domestic Cra...
  • 8/28/2017GNC in Deal with Alipay to Make Purchase Easier for Chinese Customers
  • 8/28/2017Tekni-Plex's China Manufacturing Facility Becomes Operational
  • 8/28/2017CF PharmaTech Raises CNY 440M in Series D Round Led by SDIF Fund
  • 8/28/2017Trump's Secret Weapon Against Unfair Trade Is the FCPA
  • 8/28/2017China Resources Pharma Delivers Solid Interim H1 Results
  • 8/28/2017Shanghai Pharma Reports Healthy Growth in H1 Interim Results
  • 8/28/2017CFDA Issues Announcement for Relevant Matters of Generic Drug Equivale...
  • 8/28/2017CFDA Solicits Comments on Draft Drug Data Management Guideline
  • 8/28/2017CFDA Approves Novartis's Novel Asthma Drug Xolair in China
  • 8/25/2017CFDA Issues New Policy to Promote Translation of Scientific Achievemen...
  • 8/25/2017NHFPC Reviews Healthcare Reform Policies in First Half of 2017
  • 8/25/2017CDE Solicits Comments over Sale of BE Study Drug Samples
  • 8/24/2017Asia Is the Fastest Growing Vaccine Market in the World
  • 8/24/2017IDRI, Zhejiang Hisun Agree to Co-develop Inhalable Tuberculosis Drug C...
  • 8/24/2017Reimagining the Pharmaceutical Sales Rep Model in Asia
  • 8/24/2017Recent Executive Moves
  • 8/24/2017Sinohealth: Chinese Pharma Market Growth Rebounded Somewhat in 2016 Bu...
  • 8/24/2017The Great US-China Biotechnology and Artificial Intelligence Race
  • 8/23/2017Gland Pharma, Fosun Consider Alternative 74% Acquisition Deal Option
  • 8/23/2017China Proposes New Rules to Address Perceived Anti-Competitive Practic...
  • 8/23/2017CFDA Issues Notice to Advance MAH Trial
  • 8/22/2017CFDA Issues Policies for Handling of Food and Drug Violations and Rewa...
  • 8/22/2017CFDA Issues Technical Guidelines for Pharmacokinetic / Pharmacodynamic...
  • 8/21/2017CDE Solicits Public Comments on Three Technical Guidelines
  • 8/18/2017CFDI to Initiate Clinical Data Inspection of 32 Drug Products (#13)
  • 8/18/2017CFDA Approves BMS's Baraclude as First Pediatric HBV Drug in China
  • 8/18/2017CFDA Issues Announcement to Clarify Over Published Reference Drugs for...
  • 8/18/2017Ascletis In-licenses Medivir's Novel HCV Drug Candidate
  • 8/18/201750 Domestically-listed Chinese Pharma Companies Report H1 Performance
  • Page:298/720 Total number of articles:21580: [First][<<] [296] [297] [298] [299] [300] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group